Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial

Nathan J. Brendish, Ahalya K. Malachira, Kate R. Beard, Sean Ewings, Tristan W. Clark

Source: Eur Respir J, 52 (2) 1800555; 10.1183/13993003.00555-2018
Journal Issue: August
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Nathan J. Brendish, Ahalya K. Malachira, Kate R. Beard, Sean Ewings, Tristan W. Clark. Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial. Eur Respir J, 52 (2) 1800555; 10.1183/13993003.00555-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Dyspnoea and clinical outcome in critically ill patients receiving noninvasive support for COVID-19 respiratory failure: post hoc analysis of a randomised clinical trial
Source: ERJ Open Res, 7 (4) 00418-2021; 10.1183/23120541.00418-2021
Year: 2021



Improvements in lung function with umeclidinium/vilanterol analysed by reversibility at screening: a post hoc analysis of the EMAX trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021


Impact of grouping patients by 2017 GOLD strategy assessment criteria: a post hoc analysis of the TONADO and OTEMTO trials
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017


Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial
Source: ERJ Open Res, 4 (4) 00136-2018; 10.1183/23120541.00136-2018
Year: 2018



Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial
Source: Eur Respir J 2013; 42: 1064-1075
Year: 2013



Nintedanib in IPF: post hoc analysis of the Italian FIBRONET observational study
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


A multicenter randomized trial for the effectiveness of structured discharge and follow-up protocol on readmission rate in COPD patients receiving LTOT/NIV: one-year interim analysis.
Source: International Congress 2018 – Hot topics in non-invasive ventilation
Year: 2018



Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD - a one-year follow-up randomised, controlled trial
Source: Eur Respir J 2002; 20: Suppl. 38, 67s
Year: 2002

Efficacy of aclidinium/formoterol: pooled post hoc analysis of patients naïve to COPD maintenance therapy
Source: International Congress 2017 – COPD management
Year: 2017


Cluster randomised controlled trial of the effect of introduction of an acute wheeze/asthma integrated care pathway on patient outcome
Source: Eur Respir J 2006; 28: Suppl. 50, 481s
Year: 2006

The impact of grouping patients by the 2017 GOLD COPD strategy on response to therapy: post hoc results from the TONADO tiotropium+olodaterol trials
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017


Predictors of loss of asthma control in the Phase 2a INCONTRO trial: A post-hoc analysis
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020


The minimal important difference for the 1-minute sit-to-stand test following pulmonary rehabilitation in patients with COPD – a prospective observational trial
Source: International Congress 2018 – Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients
Year: 2018

Evaluation of a method for establishing biologic quality control ranges from the first 20 acceptable test sessions in a large multi-center study
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009


Evaluation of biological quality control variance in a multi-center clinical trial for inhaled insulin
Source: Annual Congress 2007 - Quality, sleep and physiology
Year: 2007



Evaluation of factors to consider prior to adjustment of biologic quality control ranges using data from a large multi-centre clinical trial
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009


A trial like ALIC4E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?
Source: ERJ Open Res, 4 (2) 00046-2018; 10.1183/23120541.00046-2018
Year: 2018



Effect of C-reactive protein point of care testing and clinician communication skills training on antibiotic use and patient recovery in lower respiratory tract infections: a cluster randomised trial
Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care
Year: 2008


Do marker states improve measurement properties of utility instruments: a randomized multi-center trial in patients with chronic respiratory disease
Source: Eur Respir J 2004; 24: Suppl. 48, 295s
Year: 2004

Randomized, single blinded, controlled, parallel clinical trial that evaluates the effectiveness of assisted autogenic drainage in infants with RSV bronchiolitis
Source: Annual Congress 2010 - Mucous clearance and treatment modalities in respiratory physiotherapy
Year: 2010